Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 2 TO FORM S-1 - Spark Therapeutics, Inc. | d776249ds1a.htm |
| EX-5.1 - EX-5.1 - Spark Therapeutics, Inc. | d776249dex51.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Spark Therapeutics, Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Philadelphia, Pennsylvania
January 28, 2015